Superworth

Amylyx Pharmaceuticals profit margin AMLX

Gross, operating and net profit as a share of revenue over the last twelve months, from 2023.

Net margin, 12 months
n/m
a quarter missing
Peer median
13.3%

Amylyx Pharmaceuticals' net margin over the last twelve months can't be worked out yet: a quarter of its results is missing from our data.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025n/an/an/a
FY2024n/an/an/a
FY202312.9%10.2%93.3%
FY2022n/an/an/a
FY2021n/an/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26n/an/an/a
Q1 FY26n/an/an/a
Q4 FY25n/an/an/a
Q3 FY25n/an/an/a
Q2 FY25n/an/an/a
Q1 FY25n/an/an/a
Q4 FY24n/an/an/a
Q3 FY24n/an/an/a
Q2 FY24−55.5%−17.6 pts−59.5%
Q1 FY24−17.9%n/a−20.4%
Q4 FY2312.9%n/a10.2%
Q3 FY230.6%n/a−2.6%

Against its peers

Companies in Drug Manufacturers - General nearest Amylyx Pharmaceuticals' size, closest first, today.

CompanyProfit margin
AMLXAmylyx Pharmaceuticalsn/m
NRIXNurix Therapeutics42.0%
OGNOrganon3.4%
LQDALiquidia30.7%
ARQTArcutis Biotherapeutics6.1%
PBHPrestige Consumer Healthcare15.6%
INDVIndivior Pharmaceuticals26.7%
HRMYHarmony Biosciences18.9%
ANIPANI Pharmaceuticals11.1%
PAHCPhibro Animal Health6.6%
KNSAKiniksa Pharmaceuticals International9.6%
Peer median13.3%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Amylyx Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.